Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma
- 15 July 1993
- Vol. 72 (2) , 405-409
- https://doi.org/10.1002/1097-0142(19930715)72:2<405::aid-cncr2820720215>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemesInternational Journal of Radiation Oncology*Biology*Physics, 1988
- The enigma of accelerated hyperfractionated radiation therapy for head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- A New International Staging System for Lung CancerChest, 1986
- Biologic basis for altered fractionation schemesCancer, 1985
- Accelerated fractionation vs hyperfractionation: Rationales for several treatments per dayInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958